Navigation Links
Optiqua-NTU partnership to develop next-generation sensor technology
Date:2/15/2011

To enhance its contaminant-detection capability, Optiqua Technologies Pte Ltd is collaborating with Nanyang Technological University (NTU) to tap on its expertise in biomolecular sciences and sensor technology.

Optiqua, a subsidiary of Dutch optical sensor company Optisense, provides the international water industry with innovative products that offer high quality monitoring applications for the detection of contaminants in water. The sensor technology company aims to develop in Singapore the next-generation version of its optical sensor that can be used to detect specific target substances in water, and for medical diagnostics applications.

This is where NTU's Centre for Biomimetic Sensor Science (CBSS), with its research and development expertise in sensor science, comes into the picture. The centre, which specialises in biosensing technology, develops biosensors that can detect molecules in small amounts of blood, or pick out traces of toxins and harmful agents in water. This has potential applications in biomedical research, food production and homeland security.

The collaborative research will be supervised and coordinated by Professor Bo Liedberg and Assistant Professor Zhang Hua, who will be the principal investigator and co-investigator respectively.

Professor Liedberg, a visiting professor at NTU's School of Materials Science and Engineering, has produced cutting-edge work at the interface between nanomaterials and biomolecular science, and its application as optical biosensors. His research is primarily devoted to soft materials science, including surface chemistry, self-assembly, supramolecular chemistry and biomimetics. A significant portion of his work is devoted to applications in biology and medicine, for example in biosensing and molecular recognition, and the development of novel transduction principles for biochemical/biological sensing and biomedical diagnostics.

Said Professor Liedberg, who is also CBSS Director: "One of the centre's missions is to initiate collaborative research projects with bioanalytical companies in Singapore. This project with Optiqua offers excellent opportunities to test our achievements in bioassaying and biomolecular sciences on a very attractive optical sensor platform."

To this end, Optiqua is setting up a dedicated lab and research team at the CBSS which will be fully up and running in the first quarter of 2011.

On the collaboration with NTU, Optiqua's Managing Director, Mr Melchior van Wijlen, said: "The international water industry has a strong desire for innovative monitoring approaches that can overcome the shortcomings of traditional monitoring solutions. This collaboration with NTU will accelerate our R&D in biochemistry and help us to develop even more innovative real-time monitoring solutions for the industry."

"Once the next-generation biochemistry technology has been tested and selected, we will also use our optical sensor platform to develop a line of commercial products for medical Point-of-Care applications. We believe that Singapore provides a unique scientific and business environment that will help us to successfully develop and launch these applications on a global scale," he added.

NTU's President-Designate and Provost, Professor Bertil Andersson, said: "This project, at the interface between Bioanalytics, Biomedicine and Materials Engineering, is very strategic for NTU. It has great potential to lead to commercial and economical benefits for Singapore."


'/>"/>

Contact: Melchior van Wijlen
melchior.van.wijlen@optiqua.com
Nanyang Technological University
Source:Eurekalert

Related biology news :

1. GUMC and Oak Ridge National Labs announce unique research partnership
2. NIH funds 16 Science Education Partnership Awards
3. Montana State partnership receives $66.9M for carbon sequestration
4. New publishing partnership for Energy for Sustainable Development
5. International public-private partnership offers new paradigm for medicinal chemistry
6. National Lung Cancer Partnership and LUNGevity Foundation announce 2009 grant recipients
7. NTU seals global partnerships on environmental sciences R&D
8. Oxford Journals and the International Society for Computational Biology announce new partnership
9. Regional partnership to develop algal biofuels gets backing of San Diego leaders
10. BIO-key(R) Enters Strategic Partnership With Nlets
11. BIO-key(R) Enters Strategic Partnership With Nlets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology: